eoin

I generally see JV's in the pharma space. Company A has a product but no salesforce or a product that is outside of it's sweetspot, while Company B has an existing saleforce that is currently selling products that are complementary to Company A's product.

A&B form a JV whereby A contributes the product and B contributes the salesforce. Valuation of the overall JV would be same as any other entity, although you generally would assume that the JV has a finite life and adjust accordingly. Value to either side would depend on exactly how the proceeds are split during the life of the JV.